Log In
BCIQ
Print this Print this
 

Hypoxia-inducible factor prolyl hydroxylase (HIF-PH) (EGLN)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Hypoxia-inducible factor prolyl hydroxylase (HIF-PH) (EGLN)

BCIQ
Print ChartPrint this
0 1 3 1 1 0 0 0
Phases of DevelopmentPreclinicalPhase IPhase IIPhase III
Cancer

1

0

0

0

Hematology

0

1

3

1




 Products Targeting Hypoxia-inducible factor prolyl hydroxylase (HIF-PH) (EGLN)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$350.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today